about
Inositol Treatment and ART Outcomes in Women with PCOSBeneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation.Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).Cardiometabolic aspects of the polycystic ovary syndrome.Recent findings concerning thiazolidinediones in the treatment of diabetes.Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovaryThe metabolic syndrome in polycystic ovary syndrome.Thiazolidinediones: effects on insulin resistance and the cardiovascular system.Comparative safety of newer oral antidiabetic drugs.Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndromeEfficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS).Clinical features, investigations and management of adolescents with polycystic ovary syndromePolycystic ovary syndrome: treatment strategies and management.Pioglitazone counteracts the tumor necrosis factor-α inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system.Insulin-like growth factor-II: its role in metabolic and endocrine disease.Treatment of polycystic ovary syndrome with insulin-lowering agents.Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep.Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
P2860
Q28077261-C87839A0-EA03-407D-9D04-081EB93D22FDQ33559740-7C3CD6F0-2205-4CFE-81D8-E1A67BAB80DBQ35606054-2931ED27-4320-4119-85CC-BCDBBFC3FFD7Q36287892-0181CAF2-8745-4751-8118-FEC8D7642822Q36407304-24B5D112-2B2A-4675-9465-EA542282CFE7Q36426752-AF83B524-DBE2-437F-B3EC-C0A90EA0A454Q36472269-606069B4-AE8C-41FE-83CF-6998EE27F663Q36484662-2FEFB168-C0BA-42CC-8C27-D1CE7D7A16F1Q36624990-BBE7AD14-FE22-4FC7-82B2-1136E5A35622Q37019676-207092E2-A863-4FAE-AE93-62B28A0ED92CQ37050696-8C97411F-58DC-45EE-BAC6-6720BE03043AQ37294042-35F067AA-9156-432E-808E-D7654D902822Q37327330-2374674C-1AEC-4B7D-B822-B44B44285E1FQ37361691-0CC0E622-2008-4FEF-ACCA-FF2466F2E310Q38193208-D01290CA-3BE9-4A41-A4A3-674A6A4F9D10Q44084386-360F0998-06F1-439B-8554-0428BB619141Q44532471-46041527-1AE9-4EBD-BFD3-B8A21318F572Q46877696-A9B48BEE-3EA7-498F-B9A8-9E051DFBE571Q47198726-F6D42FCA-8DF7-4246-8BFC-B0AC6858F25C
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Insulin-lowering drugs in polycystic ovary syndrome.
@ast
Insulin-lowering drugs in polycystic ovary syndrome.
@en
Insulin-lowering drugs in polycystic ovary syndrome.
@nl
type
label
Insulin-lowering drugs in polycystic ovary syndrome.
@ast
Insulin-lowering drugs in polycystic ovary syndrome.
@en
Insulin-lowering drugs in polycystic ovary syndrome.
@nl
prefLabel
Insulin-lowering drugs in polycystic ovary syndrome.
@ast
Insulin-lowering drugs in polycystic ovary syndrome.
@en
Insulin-lowering drugs in polycystic ovary syndrome.
@nl
P1476
Insulin-lowering drugs in polycystic ovary syndrome.
@en
P2093
P304
P356
10.1016/S0889-8545(05)70191-1
P577
2001-03-01T00:00:00Z